A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Filgrastim
Related studies linked through entity extraction aliases.
A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Comparison of Quality and Quantity of M-PRP Cellular Content Filgrastim vs. Pegfilgrastim
- Status
- COMPLETED
- Phase
- N/A
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- Status
- RECRUITING
- Phase
- PHASE2
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
GM-CLAG in Relapsed/Refractory FLT3-mutated AML
- Status
- WITHDRAWN
- Phase
- PHASE1
Venetoclax to Augment Epigenetic Modification and Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE1
Cryopreserved MMUD BM With PTCy for Hematologic Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1
Off-the-shelf NK Cells + SCT for Myeloid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)
- Status
- RECRUITING
- Phase
- PHASE2
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE4
Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
- Status
- RECRUITING
- Phase
- PHASE2
Severe Bullous Drug Eruption and Filgrastim
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Clinical Specimen Collection From Pompe Disease Patients
- Status
- UNKNOWN
- Phase
- N/A
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Part II: Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia
- Status
- RECRUITING
- Phase
- PHASE2